1. Reporting of immune checkpoint inhibitor-associated myocarditis. Issue 10145 (4th August 2018) Authors: Noseda, Roberta; Magro, Lara; Stathis, Anastasios; Ceschi, Alessandro Journal: Lancet Issue: Volume 392:Issue 10145(2018) Page Start: 383 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Pembrolizumab in relapsed or refractory Richter syndrome. (16th June 2020) Authors: Armand, Philippe; Murawski, Niels; Molin, Daniel; Zain, Jasmine; Eichhorst, Barbara; Gulbas, Zafer; Hawkes, Eliza A.; Pagel, John M.; Phillips, Tycel; Ribrag, Vincent; Svoboda, Jakub; Stathis, Anastasios; Chatterjee, Arkendu; Orlowski, Robert; Marinello, Patricia; Christian, Beth Journal: British journal of haematology Issue: Volume 190:Number 2(2020) Page Start: e117 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Bromodomain and Extra-Terminal domain inhibitors for lymphoid malignancies. Issue 4 (July 2019) Authors: Bertoni, Francesco; Stathis, Anastasios Journal: Current opinion in hematology Issue: Volume 26:Issue 4(2019:Jul.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Single and combined BTK and PI3Kδ inhibition with acalabrutinib and ACP‐319 in pre‐clinical models of aggressive lymphomas. (29th July 2019) Authors: Spriano, Filippo; Tarantelli, Chiara; Gaudio, Eugenio; Gerlach, Magdalena M.; Priebe, Valdemar; Cascione, Luciano; Bernasconi, Elena; Targa, Altea; Mascia, Michele; Dirnhofer, Stefan; Stathis, Anastasios; Zucca, Emanuele; Bertoni, Francesco Journal: British journal of haematology Issue: Volume 187:Number 5(2019) Page Start: 595 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Targeting the DNA damage response: PARP inhibitors and new perspectives in the landscape of cancer treatment. (December 2021) Authors: Genta, Sofia; Martorana, Federica; Stathis, Anastasios; Colombo, Ilaria Journal: Critical reviews in oncology/hematology Issue: Volume 168(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. A phase-II study of atezolizumab in combination with obinutuzumab or rituximab for relapsed or refractory mantle cell or marginal zone lymphoma or Waldenström's macroglobulinemia. Issue 5 (16th April 2022) Authors: Panayiotidis, Panayiotis; Tumyan, Gayane; Thieblemont, Catherine; Ptushkin, Vadim V.; Marin-Niebla, Ana; García-Sanz, Ramon; Le Gouill, Steven; Stathis, Anastasios; Bottos, Alessia; Hamidi, Habib; Katz, Pablo; Perretti, Thomas; Willis, Jenna C.; Buske, Christian Journal: Leukemia & lymphoma Issue: Volume 63:Issue 5(2022) Page Start: 1058 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. A Phase II Study to Assess the Safety and Efficacy of the Dual mTORC1/2 and PI3K Inhibitor Bimiralisib (PQR309) in Relapsed, Refractory Lymphoma. Issue 11 (27th November 2021) Authors: Collins, Graham P.; Eyre, Toby A.; Schmitz-Rohmer, Debora; Townsend, William; Popat, Rakesh; Giulino-Roth, Lisa; Fields, Paul A.; Krasniqi, Fatime; Soussain, Carole; Stathis, Anastasios; Andjelkovic, Nebojsa; Cunningham, David; Mandic, Danijela; Radulovic, Sinisa; Tijanic, Ivan; Horowitz, Netanel... Journal: HemaSphere Issue: Volume 5:Issue 11(2021) Page Start: e656 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. A phase I trial of inotuzumab ozogamicin in combination with temsirolimus in patients with relapsed or refractory CD22-positive B-cell non-Hodgkin lymphomas. Issue 1 (2nd January 2022) Authors: Pirosa, Maria C.; Zhang, Lu; Hitz, Felicitas; Novak, Urban; Hess, Dagmar; Terrot, Tatiana; Pascale, Mariarosa; Mazzucchelli, Luca; Bertoni, Francesco; Cavalli, Franco; Zucca, Emanuele; Stathis, Anastasios Journal: Leukemia & lymphoma Issue: Volume 63:Issue 1(2022) Page Start: 117 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue of the Salivary Glands: A Multicenter, International Experience of 248 Patients (IELSG 41). (12th August 2015) Authors: Jackson, Amie E.; Mian, Michael; Kalpadakis, Christina; Pangalis, Gerassimos A.; Stathis, Anastasios; Porro, Elena; Conconi, Annarita; Cortelazzo, Sergio; Gaidano, Gianluca; Guillermo, Armando Lopez; Johnson, Peter W.; Martelli, Maurizio; Martinelli, Giovanni; Thieblemont, Catherine; McPhail, Ell... Journal: Oncologist Issue: Volume 20:Number 10(2015) Page Start: 1149 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Zandelisib with continuous or intermittent dosing as monotherapy or in combination with rituximab in patients with relapsed or refractory B-cell malignancy: a multicentre, first-in-patient, dose-escalation and dose-expansion, phase 1b trial. Issue 8 (August 2022) Authors: Pagel, John M; Soumerai, Jacob D; Reddy, Nishitha; Jagadeesh, Deepa; Stathis, Anastasios; Asch, Adam; Salman, Huda; Kenkre, Vaishalee P; Iasonos, Alexia; Llorin-Sangalang, Judith; Li, Joanne; Zelenetz, Andrew D Journal: Lancet oncology Issue: Volume 23:Issue 8(2022) Page Start: 1021 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗